Sandoz: Pyzchiva approved in the United States
Stelara is approved to treat adult and pediatric patients with diseases such as plaque psoriasis, active psoriatic arthritis, Crohn's disease and ulcerative colitis.
In addition, the FDA has provisionally determined that Pyzchiva would be interchangeable with the reference drug, as it is currently subject to an unexpired exclusivity period for the first interchangeable biosimilar biologics.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction